Molecule intelOpportunity: LowerEssential

Netilmicin

11 brands · 7 companies · product forms

ATC: J01GB07, S01AA23

Opportunity snapshot

Launch attractiveness
31
Market saturation
18
Price room
18
Regulatory risk
0
11
brands
7
companies
Rs 268.85
median price
5
price points
1.71x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 27%

3 brands · 27%
1 brands · 9%
1 brands · 9%

Price room

Across observed sources and strengths
CheapestRs 251.93
MedianRs 268.85
Most expensiveRs 431.54
Spread1.71×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 1.71x across 5 trusted points (Rs 251.93-431.54). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 2 live products for Netilmicin — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(18) + 20% low-competition(82) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

7 canonical companies and 11 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 1.71x across 5 trusted points (Rs 251.93-431.54). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.